awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34086522-009F240B-DAE9-48D8-89D9-247906707551
Q34086522-009F240B-DAE9-48D8-89D9-247906707551
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34086522-009F240B-DAE9-48D8-89D9-247906707551
Measurement of rivaroxaban and apixaban in serum samples of patients.
P2860
Q34086522-009F240B-DAE9-48D8-89D9-247906707551
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34086522-009F240B-DAE9-48D8-89D9-247906707551
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7712c0a445107ac7fc8c614c90baf4e34a19fe9d
P2860
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies.